Please check your internet connection and try again.
# Sompraz hp
## Overview
Sompraz hp is a combination medication containing **esomeprazole**, **amoxicillin**, and **clarithromycin**. It is used for the eradication of *Helicobacter pylori* infection in patients with peptic ulcer disease.
## Primary Indications
* Eradication of *Helicobacter pylori* in patients with peptic ulcer disease.
## Adult Dosing
The typical adult regimen involves taking the components of Sompraz hp as follows:
* **Esomeprazole:** 20 mg orally twice daily.
* **Amoxicillin:** 1000 mg orally twice daily.
* **Clarithromycin:** 500 mg orally twice daily.
This regimen is generally taken for **7 to 14 days**. Specific duration depends on local guidelines and clinical judgment.
## Pediatric Dosing
Pediatric dosing is not specifically established for the Sompraz hp combination product. Dosing of individual components would need to be considered based on age, weight, and the specific indication. Consultation with a pediatric specialist is recommended.
## Dose Adjustments
* **Renal Impairment:** Amoxicillin requires dose adjustment in severe renal impairment (CrCl < 30 mL/min). Clarithromycin also requires dose adjustment in severe renal or hepatic impairment. Esomeprazole does not typically require dose adjustment for renal impairment.
* **Hepatic Impairment:** Clarithromycin requires dose adjustment in moderate to severe hepatic impairment. Esomeprazole may require dose reduction in severe hepatic impairment.
## Contraindications
* Hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of allergic reactions to penicillins.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Concomitant use of ergotamine or dihydroergotamine.
* Use in patients with a history of QT prolongation or ventricular arrhythmias, or with electrolyte disturbances (hypokalemia, hypomagnesemia).
## Adverse Effects
Common adverse effects include:
* **Gastrointestinal:** Diarrhea, nausea, abdominal pain, vomiting, altered taste.
* **Allergic Reactions:** Rash, urticaria, anaphylaxis (rare).
* **Other:** Headache, fungal infections.
Clarithromycin: QT prolongation, liver dysfunction, *Clostridium difficile*-associated diarrhea.
Amoxicillin: Hypersensitivity reactions, *Clostridium difficile*-associated diarrhea.
Esomeprazole: Fractures (hip, wrist, spine), *Clostridium difficile*-associated diarrhea, low magnesium levels, vitamin B12 deficiency.
## Key Drug Interactions
* **Clarithromycin:** Potent inhibitor of CYP3A4. Interacts with numerous drugs metabolized by CYP3A4 (e.g., statins, warfarin, digoxin, certain antifungals, sedatives). Concomitant use with colchicine can be fatal. Ergotamine and dihydroergotamine are contraindicated.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
* **Esomeprazole:** Can alter the absorption of drugs that rely on gastric pH (e.g., ketoconazole, itraconazole, digoxin). May increase levels of certain drugs metabolized by CYP2C19 or CYP3A4.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Monitor for *Clostridium difficile*-associated diarrhea.
* Monitor liver function tests, especially with clarithromycin.
* Consider magnesium levels with prolonged esomeprazole use.
* Assess for successful *H. pylori* eradication via breath test or stool antigen test after completion of therapy.
## Clinical Pearls
* Administer the entire contents of the Sompraz hp pack (containing separate capsules/tablets) as directed.
* Take esomeprazole at least 1 hour before meals. Amoxicillin and clarithromycin can be taken with or without food.
* Ensure the patient completes the full course of therapy, even if symptoms improve.
* Counsel patients on potential adverse effects and drug interactions, especially those related to clarithromycin.
***
*This information is intended for healthcare professionals. Always verify the most current prescribing information with the manufacturer's official product insert or a reliable drug information database before making clinical decisions.*